Monitorforhire.com Signs Agreement with Global CINRG
Monitorforhire.com (MFH) has signed an agreement with Global CINRG to provide monitors for their clinical trials.
PHILADELPHIA, May 17, 2005-Monitorforhire.com (MFH) has signed an agreement with Global CINRG to provide monitors for their clinical trials. The agreement will provide the Sacramento, Ca.-based clinical research management organization (RMO) with access to more than 2,000 qualified, pre-screened clinical monitors worldwide with expertise in a variety of therapeutic specialties.
"We are delighted to be working with Global CINRG," said Scott Freedman, president, Monitorforhire.com. "As the only web-based provider of clinical monitoring services, we are uniquely positioned to help Global CINRG meet its goals."
Global CINRG is a worldwide clinical research management organization. They combine extensive international research competence with a prescreened, pre-qualified global research enrollable patient database (REDbase).
Monitorforhire.com has registered monitors located in all 50 states of the US. and 28 countries worldwide. Its growing client base currently consists of more than 300 clinical sponsors including major pharmaceutical, biotechnology companies, academic institutions and CROs.
About Monitorforhire.com
Monitor for hire is the leading web-enabled resource management company providing qualified, regional independent clinical monitors to the pharmaceutical, biotechnology, medical device and contract research industries. The service allows registered sponsors to query the online system for pre-qualified, available monitors by therapeutic experience, indication experience and geographic location. Monitorforhire.com has offices in Philadelphia, Pa. and San Diego, Ca. For more information, please visit www.monitorforhire.com or call (610) 862.0909 on the U.S. East Coast or (858) 453.8030 on the West Coast.
Unifying Industry to Better Understand GCP Guidance
May 7th 2025In this episode of the Applied Clinical Trials Podcast, David Nickerson, head of clinical quality management at EMD Serono; and Arlene Lee, director of product management, data quality & risk management solutions at Medidata, discuss the newest ICH E6(R3) GCP guidelines as well as how TransCelerate and ACRO have partnered to help stakeholders better acclimate to these guidelines.
FDA Grants Priority Review to Merck’s sBLA for Winrevair After Early Success in ZENITH PAH Trial
July 2nd 2025Merck’s bid to update Winrevair’s label advances with FDA priority review, backed by Phase III ZENITH data showing a 76% reduction in major morbidity and mortality events in patients with pulmonary arterial hypertension.
